SALIX PHARMACEUTICALS LTD Deferred Tax Assets, Net of Valuation Allowance
SALIX PHARMACEUTICALS LTD had Deferred Tax Assets, Net of Valuation Allowance of $487.87 million as of 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2015-03-02
- 2014-12-31: Deferred Tax Assets, Net of Valuation Allowance $487.87M.
- 2014-09-30: Deferred Tax Assets, Net of Valuation Allowance $146.70M.
- 2014-06-30: Deferred Tax Assets, Net of Valuation Allowance $146.70M; Deferred Tax Assets, Net of Valuation Allowance as first filed $147.50M.
- 2014-03-31: Deferred Tax Assets, Net of Valuation Allowance $146.70M; Deferred Tax Assets, Net of Valuation Allowance as first filed $147.50M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance | Deferred Tax Assets, Net of Valuation Allowance as first filed |
|---|---|---|
| 2014-12-31 | $487.87M 10-K · filed 2015-03-02 | |
| 2014-09-30 | $146.70M 10-Q/A · filed 2015-03-02 | |
| 2014-06-30 | $146.70M 10-Q/A · filed 2015-03-02 | $147.50M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $146.70M 10-Q/A · filed 2015-03-02 | $147.50M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $148.41M 10-K · filed 2015-03-02 | $149.40M 10-K · filed 2014-02-28 |
| 2012-12-31 | $119.68M 10-K · filed 2015-03-02 | |
| 2011-12-31 | $119.37M 10-K · filed 2013-03-01 | $118.46M 10-K · filed 2012-02-28 |
| 2010-12-31 | $38.20M 10-K · filed 2012-02-28 |